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Abstract 21 
 22 
Loeys-Dietz syndrome (LDS) is an autosomal dominant connective tissue disorder 23 
with a range of cardiovascular, skeletal, craniofacial and cutaneous manifestations. 24 
LDS type 4 is caused by mutations in TGFβ ligand 2 (TGFB2) and based on the 25 
family pedigrees described to date, appears to have a milder clinical phenotype, 26 
often presenting with isolated aortic disease. We sought to investigate its molecular 27 
basis in a new pedigree. We identified a missense variant p.(Arg320Cys) 28 
(NM_003238.3) in a highly evolutionary conserved region of TGFB2 in a new LDS 29 
type 4 pedigree with multiple cases of aortic aneurysms and dissections.  There was 30 
striking up-regulation of TGFB1 and TGFB2 expression on immunofluorescent 31 
staining and western blotting of the aortic tissue from the index case confirming the 32 
functional importance of the variant. This case highlights the striking paradox of 33 
predicted loss-of-function mutations in TGFB2 causing enhanced TGFβ signaling in 34 
this emerging familial aortopathy. 35 
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Introduction 44 
 45 
Loeys-Dietz syndrome (LDS) is an inherited autosomal dominant (AD) systemic 46 
disorder with a broad phenotypic spectrum of cardiovascular, skeletal, craniofacial 47 
and cutaneous manifestations (OMIM #609192).  The hallmark of early and 48 
progressive aortic root dilatation, predisposes to premature death from dissection 49 
and rupture of the aorta [1]. Other classic features include widespread arterial 50 
tortuosity, bicuspid aortic valve, bifid uvula/cleft palate and hypertelorism [1].  LDS is 51 
caused by disruption to the transforming growth factor beta (TGFβ) signaling 52 
pathway. TGFβ proteins regulate key processes including cell proliferation, 53 
angiogenesis and matrix turnover by signaling through serine/threonine kinase 54 
receptors (TGFBR1, TGFBR2) and downstream effectors, the SMAD proteins [2].  55 
TGFβ is synthesized as a dimer bound to a latency associated peptide (LAP) that 56 
prevents the cytokine from binding to its receptors [3]. Complex mechanisms also 57 
control TGFβ sequestration and release by the extracellular matrix (ECM) [3].  58 
Mutations in TGFBR1, TGFBR2, TGFβ ligands 2 and 3 (TGFB2, TGFB3) and 59 
SMAD3 are associated with LDS disease pathogenesis [4-7]. Precise genotype-60 
phenotype correlations are still lacking, but it is proposed that a mutation in any of 61 
these genes plus arterial aneurysm/dissection or a family history of LDS is sufficient 62 
for the diagnosis [8].  LDS type 4 is caused by mutations in TGFB2 and represents a 63 
milder end of the LDS spectrum often with isolated aortic disease presenting in the 64 
mid-thirties [9]. To date, less than 20 mutations in TGFB2 have been identified 65 
usually in the LAP domain of the protein [6, 9-13]. However, the underlying 66 
pathogenic mechanisms remain unclear. Most of the mutations are predicted to be 67 
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loss-of-function, but their downstream effect appears to be a paradoxical activation 68 
of TGFβ signaling [14].  69 
Here we report a new pedigree with LDS4 and confirm that the causative 70 
variant p.(Arg320Cys) (NM_003238.3) causes striking upregulation of TGFB1/2 71 
expression in the aorta. This confirms that the variant is functional and corroborates 72 
previous reports of an enhanced aortic TGFβ “tissue signature” in LDS and other 73 
TGFβ vasculopathies. 74 
 75 
Materials and Methods 76 
 77 
Data Submission 78 
Phenotype and variant data were submitted into LOVD v.3.0 Build 16 79 
http://medgen.ua.ac.be/LOVDv.3.0/individuals/00000322. 80 
 81 
Control Subjects 82 
Formalin-fixed and paraffin embedded (FFPE) aortic tissue from age and gender 83 
matched donors (n=5) were obtained from the Transplant service at Addenbrooke’s 84 
Hospital (Cambridge, UK). All samples were handled in accordance with the policies 85 
and procedures of the Human Tissue Act and had Local and Regional Ethics 86 
approval.  87 
 88 
Immunofluorescence staining 89 
FFPE sections of the surgical specimen were deparaffinised in Histoclear (National 90 
Diagnostics, Atlanta, GA, USA) then dehydrated through graduated methanols. 91 
Antigen retrieval was performed in pH6 citrate buffer (Vector Laboratories Ltd, 92 
Peterborough, UK) using 2100 Retriever (Aptum Biologics Ltd, Southampton, UK). 93 
Sections were permeabilised with 0.05% v/v Triton X‐100–PBS for 5 min and 94 
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blocked for 2 h at room temperature with 5% v/v goat serum in 0.05% v/v Triton™ X‐95 
100–PBS. Sections were probed with mouse monoclonal to TGFB2 (Abcam, 96 
Cambridge, UK) and mouse monoclonal to TGFB1 (Abcam) for 16 h at 4°C at 1:200 97 
dilution in 2% v/v goat serum in 0.05% v/v Triton™ X‐100–PBS. Slides were then 98 
washed for 5 min in 0.05% v/v Triton™ X‐100–PBS and incubated in secondary 99 
antibody for 1 h at room temperature. Pre‐absorbed goat IgG‐conjugated Alexa 100 
Fluor® 633 secondary antibody (ThermoFisher Scientific, Waltham, MA, USA) was 101 
used at 1:200 dilution in 2% v/v goat serum in 0.05% v/v Triton™ X‐100–PBS. 102 
Sections were counterstained with Sytox® Orange (ThermoFisher Scientific) at 103 
1/10,000 in Milli-Q® water for 20 min at room temperature then mounted with 104 
ProLong® Gold Antifade Mountant (ThermoFisher Scientific).  105 
Images were acquired with a Leica SP8 (Leica Microsystems, Wetzlar, 106 
Germany) inverted laser scanning confocal microscope using a 20X 1.4 N.A. dry 107 
objective. Acquisition parameters were: 12-bit, 1024 x 1024 pixels, 1.25x and 3x 108 
digital zooms, 8000 Hz scan speed, 16-line Kalman filtering and 2 frame 109 
accumulation. All images were acquired using identical scan settings.  110 
 111 
Protein Extraction and Western blotting  112 
Western blotting for TGFB1 and TGFB2 was performed in the case and two of the 113 
controls.  Three 15μm FFPE sections of each tissue sample were deparaffinised in 114 
Histoclear® 3 times. The procedure was serially repeated with 100%, 95% and 70% 115 
ethanol, washing twice for 10 min each. Pellets were air dried, re-suspended in 116 
Extraction Buffer EXB Plus (Qiagen, Hilden, Germany) containing β-117 
mercaptoethanol and incubated at 4°C for 5 min then at 100°C for 20 min followed 118 
by a 2 h incubation at 80°C with agitation and a final incubation at 4°C for 1 min. 119 
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Samples were then centrifuged at 4°C for 15 min and the protein quantified using 120 
PierceTM BCA protein assay (ThermoFisher Scientific) and stored at -70°C until 121 
further use.  122 
Ten μg of protein lysates were used for the western blot. Samples were 123 
incubated at 70°C for 10 min in Lithium dodecylsulfate (LDS) sample loading buffer 124 
(ThermoFisher Scientific) and Bolt® sample reducing agent (ThermoFisher 125 
Scientific). Samples for TGFB1 blotting were performed under non-reducing 126 
conditions. Protein was separated by SDS-gel electrophoresis in 4-12% gradient Bis-127 
Tris Plus Bolt® gels (ThermoFisher Scientific) at 200V for 30 min and transfered to 128 
0.22μM nitrocellulose membrane (ThermoFisher Scientific) using the iBlot2 dry 129 
blotting system (ThermoFisher Scientific) at 20V for 10 min. Prior to transfer, gels 130 
were equilibrated for 5min in NuPage transfer buffer (ThermoFisher Scientific) 131 
containing 10% methanol. Membranes were blocked with 5% w/v milk in TBS buffer 132 
for 1 h at room temperature then incubated with primary antibodies in 5% milk w/v in 133 
0.1% v/v Tween® 20-TBS for 16 h at 4°C. Anti-TGFB2 (Abcam) rabbit polyclonal IgG 134 
antibody was used at 1:500 dilution and β-actin mouse monoclonal IgG 135 
(ThermoFisher Scientific) was used as a loading control at 1:1000 dilution. Anti-136 
TGFB1 (Abcam) mouse monoclonal IgG antibody was used at 1:500 dilution and β-137 
actin rabbit polyclonal IgG (Sigma Aldrich, St Louis, MO, USA) was used as a 138 
loading control at 1:1000 dilution. Secondary antibodies were incubated in 0.1% v/v 139 
Tween® 20-TBS for 1 h at room temperature. Donkey anti-rabbit (LI-COR  140 
Biotechnology UK Ltd, Cambridge, UK) IRDye® 800CW and goat anti-mouse 141 
(ThermoFisher Scientific) Alexa Fluor® 680 conjugated secondary antibodies were 142 
used at 1:5000 dilution. Membranes were washed in 0.1% v/v Tween® 20-TBS 3 143 
times for 15 min each between primary and secondary antibody incubations and 144 
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before visualization. Protein bands were detected using the LI-COR Odessey 145 
system. Signal intensities were normalised against β-actin and quantified using 146 
ImageStudioLite software. 147 
 148 
Results 149 
 150 
Pedigree discovery 151 
A 27-year-old man presented with severe pain radiating down his back after lifting a 152 
lawn mower into a van. The family history revealed several family members with 153 
aortic aneurysms and dissections: his mother (III:6) died following an aortic 154 
dissection, a maternal uncle (III:1) had emergency repair of an aortic aneurysm and 155 
his maternal grandfather (II:3) had a dissection of an abdominal aortic aneurysm and 156 
separate iliac artery aneurysms (Figure 1A). On examination, the only sign was an 157 
elevated BP of 240/100 mmHg. A CT scan with contrast showed a Stanford type-A 158 
dissection with an intimal flap extending the full length of the aorta from the aortic 159 
valve into both iliac arteries (Figure 1B). He underwent open aortic repair and a 160 
surgical specimen was recovered for further examination.  Histologic examination 161 
showed fragmentation and disruption of the aortic elastic fibers and cystic medial 162 
necrosis (Figure 1C). 163 
 164 
Sequencing and variant identification 165 
DNA sequencing from the peripheral blood of the index case identified a missense 166 
variant (c.958C>T) (NM_003238.3) in exon 6 of the TGFB2 gene (NG_027721.1). 167 
This variant causes a p.(Arg320Cys) substitution in a highly conserved region of 168 
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TGFB2 (Figure 1D). The variant was also detected in the uncle (III:1) and two 169 
currently asymptomatic teenage family members (IV:3) and (IV:5). 170 
 171 
TGFB1 and TGFB2 expression in the aorta 172 
Immunofluorescent imaging showed markedly enhanced TGFB1 and TGFB2 173 
expression in the aorta of the index case compared to age and gender-matched 174 
controls (Figure 2 and 3).  This was confirmed by immunoblotting for both proteins in 175 
the aorta of IV:10 versus controls where the upregulation of TGFB1 was particularly 176 
striking (Figure 2 and 3). 177 
 178 
Discussion 179 
 180 
The p.(Arg320Cys) substitution is in a highly evolutionarily conserved region of 181 
TGFB2 and has a strong in silico prediction for pathogenicity [11].  However, there 182 
has been no evidence to confirm its functional effects [11].  We show for the first time 183 
that this variant does induce striking up-regulation of both TGFB1 and TGFB2 in the 184 
vessel wall of a subject with the variant. While this is unexplained by a loss-of-185 
function variant in TGFB2, this signature of enhanced TGFβ signaling is believed to 186 
play a central role in the aortic dilatation and aneurysms seen in LDS, Marfan 187 
syndrome and other inherited aortopathies[15]. 188 
Of note, haploinsufficient TGFB2+/- mice develop aortic root dilatation and 189 
aneurysm and have a higher expression of phosphorylated SMAD2/3 and 190 
extracellular signal-regulated kinases (ERK1/2), indicating up-regulation of the TGFβ 191 
canonical (SMAD dependent) and non-canonical (SMAD independent) pathways [6]. 192 
The canonical pathway is involved in stimulating elastin and collagen while 193 
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repressing ECM degradation by inducing endogenous tissue inhibitor of 194 
metalloproteinases 1 and 3. These changes disrupt the normal architecture of the 195 
vessel wall [2]. Less is known about the role of the non-canonical pathway, however 196 
enhanced ERK activity appears to stimulate the expression of matrix 197 
metalloproteinases 2 and 9 to stimulate matrix degradation [2, 15].  198 
Another suggestion to resolve the TGFβ vascular paradox, posits that other 199 
TGFB ligands are overexpressed to compensate for haploinsufficiency of a given 200 
TGFB ligand. This shift in ligand usage is seen with higher TGFB1 expression in 201 
TGFB2+/- mice [6] and in our index case. The high TGFB1/2 expression may even be 202 
a “repair process” by mesenchymal cells following damage to ECM [3].  203 
As aortic aneurysm and dissection may be the only manifestation of LDS4, 204 
identifying family members with the variant is crucial for surveillance to improve 205 
clinical outcome. The striking activation of TGFβ signaling in these patients also 206 
suggests this may be a future therapeutic target for LDS. 207 
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Titles and legends to figures 265 
Figure 1 Clinical and Molecular Findings A. Family pedigree with multiple cases 266 
of aneurysms and dissections suggesting autosomal dominant inheritance. The 267 
variant was detected in the index case (IV:10) and III:1, IV:3 and IV:5. B. CT images 268 
showing an intimal flap (red arrows) extending from the aortic valve into the thoracic 269 
aorta. C. Elastin staining of IV:10 aorta showing extensive elastic fibre fragmentation 270 
at the site of dissection (scale bar=6mm). D. Sequencing chromatogram showing a 271 
missense mutation (c.958C>T) in exon 6 of TGFB2. The mutation is in a region of 272 
TGFB2 that is highly conserved across species. SP; signal peptide, LAP; latency-273 
associated-peptide.  274 
  275 
Figure 2 Aortic Expression of TGFB2 A. Western blots of aortic TGFB2 276 
expression in IV:10 compared to two age-matched controls, TS218 and TS199. 277 
Signal intensities of TGFB2 normalized against β Actin indicate a twofold higher 278 
expression of TGFB2 in the mutant sample. B. Immunofluorescent staining of 279 
TGFB2 (green) shows increased expression in the aortic wall of IV:10 compared to 280 
TS218 and TS199. Elastic fibres appear as blue (autofluorescence) and nuclei are 281 
counterstained red (scale bar=50uM and the right-hand images are zoomed).  282 
 283 
Figure 3 Aortic Expression of TGFB1 A. Western blots of aortic TGFB1 284 
expression in IV:10 compared to two age-matched controls, TS218 and TS199. 285 
Signal intensities of TGFB1 normalized against β Actin indicate a 15-fold higher 286 
expression of TGFB1 in the mutant sample. B. Immunofluorescent staining of 287 
TGFB1 (green) shows increased expression in the aortic wall of IV:10 compared to 288 
TS218 and TS199. Elastic fibres appear as blue (autofluorescence) and nuclei are 289 
counterstained red (scale bar=50uM and the right-hand images are zoomed). 290 
 291 



